Letters to the Editor

You are here: / Letters to the Editor

Letters to the Editor are no longer included in the main BJUI journal, but we will continue to publish them on the BJUI website as an important part of the scientific debate.

Letters Policy

  • Letters to the editor will now published in electronic form on the journal website (www.bjuinternational.com), not in the journal itself. As such, letters are not submitted to PubMed for indexing.
  • Letters to the editor should be 500 words or less, preference is given to concise letters.
  • Writers are limited to one letter published on the website per month.
  • Letters must include full author contact details.
  • All letters will be peer-reviewed, and we reserve the right to reject letters, or to edit them if they are accepted.
  • If accepted, letters are sent to the authors of the paper being discussed, to give them the chance to make a response that will (if accepted) be published at the same time as the letter.
  • Letters will not be open for public comment; replies must be submitted by email to the Editorial Office for review.

Re: New surgical technique for ventral penile curvature without circumcision

Sir,  While the dual concept of operating via an infrapubic incision and using a “double breasted” tunical repair technique for ventral penile curvature is interesting, Alei et al. make a number of statements which must be challenged [1]. We would concur that discussion and documentation of penile length is vital prior to surgery for penile curvature, particularly to reduce medicolegal risk. The demonstration and advice described is vital, particularly before Peyronie’s disease surgery…

Prostate cancer survivorship and psychosexual function: a silent epidemic

Sir, We were delighted to read the comment by Vasdev et al. [1]. This is an important topic relating to prostate cancer survivorship which is currently unaddressed. One of the problems survivors encounter post-therapy is psychosexual concerns [2]. These are critical to manage appropriately. With individualised treatment options, survivors may be able to gain a significant improvement in sexual function. In addition, a reduction in quality-of-life is related to sexual dysfunction after completing…

Multiparametric MRI – Is the result convincing for AS patients?

Sir, We read with interest the recent ‘Article of the Month’ by Park et al. in which they concluded that multi-parametric 3T-MRI can be used to predict adverse pathological features and to assess eligibility of patients for active surveillance (AS), in those initially meeting the PRIAS criteria [1]. Nevertheless, we would urge a degree of caution before widespread adoption of this strategy in patient selection for AS. Firstly, it is accepted that there are false positives with multi-parametric…

Bladder cancer survivorship: orthotopic neobladders vs. ileal conduit, health economics in the way of progress

1 Comment
/
Sir, It is with optimism that we read your editorial on orthotopic neobladders (ONB) vs. ileal conduits (IC) [1] and also the articles by Singh et al. [2]  and Studer et al. [3].  Collectively, these are significant articles highlighting ONB as a preferable alternative to IC in terms of quality-of-life. The differences are even more pronounced where having an IC may be ‘censured’ in some parts of the world, perhaps for cultural reasons or practical/economic reasons, such as lack of availability…

Re: Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis

Sir, In the field of non-muscle-invasive bladder cancer (NMIBC), accumulating data on hexaminolevulinate (HAL) or 5-aminolevulinic acid (5-ALA)-guided blue-light cystoscopy (BLC) show significant benefits over standard white-light cystoscopy (WLC) in terms of improved detection and reduced recurrence rates. A notable exception to this body of evidence is a meta-analysis published by Shen et al. in the BJUI in 2012 [1]. We have been puzzled by this discrepancy, which is at odds not only with our…
© 2024 BJU International. All Rights Reserved.